Assessment of a Composite Prognostic Score to Predict Severe Forms of Ischemic Colitis

Overview

Our objective is to determine a prognostic score including CT, clinical and biological criteria predicting the serious (death / surgery) or non-serious (medical treatment) evolution of ischemic colitis and therefore possibly modify the therapeutic management (propose surgical treatment for a severe form based on prognostic score).

Full Title of Study: “Assessment of a Composite Prognostic Score to Predict Severe Forms of Ischemic Colitis of Montpellier”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: November 1, 2020

Clinical Trial Outcome Measures

Primary Measures

  • Complication rate of ischemic colitis
    • Time Frame: 1 day
    • Severe (surgery and/or death) or non severe form of ischemic colitis (medical treatment) : analysis of radiological, biological and clinical data is performed at the time of acute episode of ischemic colitis when the patient is admitted to the hospital or during the stay of the patient previously present in the hospital for another condition

Participating in This Clinical Trial

Inclusion Criteria

  • Age > or = at 18 years old; – Performing an abdomino-pelvic scan injected within 6 hours of the onset of symptoms; – Ischemic colitis proven by endoscopy or surgical data. Exclusion criteria:

  • CT scan performed without injection and / or after 6 hours following the onset of symptoms; – Unproven ischemic colitis.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University Hospital, Montpellier
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Patrice TAOUREL, MD-PhD, Study Director, University Hospital, Montpellier

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.